Tower Trust & Investment Company’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.19M Buy
992
+1
+0.1% +$1.02K 0.72% 28
2026
Q1
$911K Hold
991
0.6% 42
2025
Q4
$1.06M Buy
991
+891
+891% +$852K 0.67% 37
2025
Q3
$76.3K Hold
100
0.05% 111
2025
Q2
$78K Hold
100
0.06% 113
2025
Q1
$89.9K Buy
+100
New +$83.2K 0.07% 104

Other funds holding LLY

Tower Trust & Investment Company's LLY Position: Q2 2026 in Review

Tower Trust & Investment Company increased its Eli Lilly (LLY) stake by 0.1% in Q2 2026, buying an estimated $1.02K and bringing the position to 992 shares worth $1.19M. The position accounts for 0.72% of the portfolio, ranked #28.

Tower Trust & Investment Company first reported a position in LLY in Q1 2025 and has held it in 6 quarters since. 1,844 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Tower Trust & Investment Company held 992 shares of Eli Lilly worth $1.19M as of Q2 2026.
  • Tower Trust & Investment Company bought 1 Eli Lilly share in Q2 2026, an estimated $1.02K.
  • Eli Lilly made up 0.72% of Tower Trust & Investment Company's portfolio in Q2 2026, its #28 holding.
  • Tower Trust & Investment Company first reported a position in Eli Lilly in Q1 2025 and has held it in 6 quarters since.
  • 1,844 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Tower Trust & Investment Company's 13F filing for Q2 2026, filed 9 Jul 2026.